Variable | Women | Men | P-value | OR (95%-CI) |
---|---|---|---|---|
Number of procedures | 22946 | 59358 | ||
Patient history: | ||||
Age [years] | 71.9 (64.8 – 78.3) | 66.7 (57.4 – 73.5) | <0.001 | |
Diabetes mellitus | 26.5% (5868/22154) | 20.2% (11537/57209) | <0.001 | 1.43 (1.38–1.48) |
Previous CABG | 8.2% (1885/22880) | 13.0% (7721/59200) | <0.001 | 0.60 (0.57–0.63) |
Previous PCI | 28.2% (6419/22747) | 34.7% (20432/58861) | <0.001 | 0.74 (0.72–0.76) |
Renal disease | 13.6% (2977/21943) | 13.3% (7510/56639) | 0.255 | 1.03 (0.98–1.07) |
Presentation: | ||||
STEMI | 18.2% (4182/22946) | 19.3% (11478/59358) | <0.001 | 0.95 (0.91–0.99) |
NSTE-ACS | 29.3% (6721/22946) | 27.6% (16370/59358) | 1.07 (1.04–1.11) | |
Stable CAD | 52.5% (12043/22946) | 53.1% (31510/59358) | 1a | |
Cardiogenic shock | 1.7% (388/22945) | 1.5% (894/59355) | 0.055 | 1.12 (0.99–1.27) |
Symptoms of HF | 5.6% (1296/22945) | 5.0% (2952/59355) | <0.001 | 1.14 (1.07–1.22) |
Center volume stents/year | 1150 ± 613 | 1156 ± 623 | 0.364 | |
Target lesions: | ||||
RCA | 35.0% (8039/22946) | 34.5% (20508/59358) | 0.190 | 1.02 (0.99–1.05) |
LAD | 45.9% (10526/22946) | 41.0% (24358/59358) | <0.001 | 1.22 (1.18–1.26) |
CX | 23.6% (5412/22946) | 26.9% (15972/59358) | <0.001 | 0.84 (0.81–0.87) |
Left main stem | 2.2% (504/22946) | 2.6% (1538/59358) | 0.001 | 0.84 (0.76–0.93) |
Bypass graft | 1.8% (416/22946) | 3.5% (2107/593258) | <0.001 | 0.50 (0.45–0.56) |
Implanted stents per PCI | 1.40 ± 0.75 | 1.42 ± 0.76 | <0.001 | |
In-stent restenosis | 6.5% (1499/22914) | 7.3% (4300/59293) | <0.001 | 0.90 (0.84–0.95) |
Complex stenosis (≥ B2) | 66.6% (15032/22579) | 68.3% (39860/58402) | <0.001 | 0.93 (0.90–0.96) |